Q2 sales 22.447 bln usd, up 4.3% (Il Sole 24 Ore Radiocor) - New York , 17 Jul - The US pharmaceutical group Johnson & Johnson said that in the second quarter of 2024 earnings per share decreased by 5.9% to 1.93 dollars due to one-time special charges, while adjusted EPS grew by 10.2% to 2.82 dollars.

Sales were up 4.3% to 22.447 billion dollars, with operational growth of 6.6% and adjusted operational growth of 6.5%.

Adjusted operational growth excluding Covid-19 vaccines was 7.1.%.

AAA-Hob

(RADIOCOR) 17-07-24 12:50:46 (0334) 5 NNNN